If you have active flares because of systemic lupus erythematosus, consider participating in the TOPAZ Study for SLE.
The TOPAZ Study is evaluating the safety and efficacy of an investigational medicine, compared to a placebo (an inactive substance
Author: smartrobbie
How to safely reduce biologic medications in inflammatory arthritis.
We are looking for people with well-controlled Rheumatoid and Psoriatic Arthritis (RA and PsA) on biologic or targeted-synthetic medications. The
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed
Shortage of Abatacept (Orencia®) Resolved – update
Update: August 28, 2024. Bristol Myers Squibb (BMS), the manufacturer of Orencia (abatacept), has announced that the shortage of subcutaneous
Creating a consumer-friendly version of An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis
Do you have rheumatoid arthritis, and have you ever wondered what the best course of treatment is? What medications should
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector)
Arthritis Australia, Chronic Pain Australia and Consumers Health Forum of Australia Joint Statement ABC 4 Corners “Pain Factory” episode
Tuesday 9 April 2024 Last night’s episode of ABC 4 Corners highlighted the many adverse events people living with chronic
Arthritis Australia welcomes cheaper arthritis medicines
More medicines now eligible for 60 day dispensing from March 1 2024 [Sydney, Australia] Arthritis Australia has welcomed access to
Millennials Face A Painful & Stiff Future || New Report Reveals Generations Hit Hardest with Arthritis
New forecast projections released today by Arthritis Australia reveal Millennials are facing a painful and debilitating health crisis by 2040,
Online wellbeing program for young people living with chronic conditions
Pain medicines after total hip or knee replacement We are interested in understanding what people are considering when deciding what